Mach7 Signs A$5m Licence Agreement Amendment
Key points
- 5-year licence agreement amendment with a large US-based radiology marketplace
- Total Contract Value of A$5M, a A$3M increase over the original agreement
- Extends the term of the previous subscription licence by three years
Full summary
Mach7 Technologies Limited (ASX:M7T) has announced that it has signed a 5-year licence agreement amendment for a Total Contract Value (TCV) of A$5M with a longstanding key customer, a large US-based radiology marketplace. The amended agreement is for additional eUnity Viewer and Enterprise Imaging Platform licensing and extends the term of the previous subscription licence by three years. The revised agreement is effective from 1 June 2025 and represents a A$3M increase in TCV over the original agreement. Mach7 CEO Mike Lampron stated that the agreement highlights the company's focus on building lasting relationships with customers and the importance of their 'land and expand' strategy. It also demonstrates the strength of Mach7's value proposition and the significant return on investment that their diverse product offering delivers to customers.
Summary generated by a large language model. Please interpret with care.